Abstract
The discovery of the antibacterial activity of prontosil (1) in the early 1930 s (Domagk 1935, 1957), the first effective chemotherapeutic agent to be employed for the systemic treatment of bacterial infection in humans (Foerster 1933), was the beginning of the present era of chemotherapy. The history of the development of sulfonamides as a major class of chemotherapeutic agents is one of the most fascinating chapters in drug research, highlighting the roles of skilful planning and serendipity. The synthesis of prontosil (1) was a carry-over of the interest generated in dyes in general as possible antimicrobials as a result ofE hrlich’s studies on the relationship between selective staining by dyes and their antiprotozoal activity, and in the sulfonamide group as contributory to fastness for acid wool dyes as a result of the work of Horlein, Dressel and Kethe of I.G. Farbenindustrie (see Mietzsch 1938), which led Mietzsch and Klarer (1935) to synthesize a group of azo dyes containing a sulfonamide group, which included prontosil. The lack of correlation between in vitro and in vivo antibacterial tests prompted Domagk (1935) to resort to in vivo testing, a very fortunate decision, since otherwise the fate of sulfonamides might have been different. In fact, similar dyes had been synthesized almost a decade earlier, such as p-sulfonamidobenzeneazodihydrocupreine (Heidelberger and Jacobs 1919), but tested in vitro, and thus understandably showing rather poor activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adamson RH, Bridges JW, Kibby MR, Walker SR, Williams RT (1970) The fate of sulfadimethoxine in primates compared with other species. Biochem J 118: 41–45
Akiba T, Yokota T (1962) Studies on the mechanism of transfer of drug resistance in bacteria 18. Incorporation of 35S-sulfathiazole into cells of the multiple resistant strain and artificial sulfonamide resistant strain of E. coli. Med Biol 63: 155–159
Albert A (1954) The transformation of purines into pteridines. Biochem J 57: X
Anand N (1979) Sulfonamides and sulfones. In: Wolff ME (ed) Burger’s medicinal chemistry, 4th edn, Part II. Wiley and Sons, New York, p 1
Angier RB, Boothe JH, Hutchings BL, Mowat JH, Semb J, Stokstad ELR, Subba-Row Y, Waller CW, Cosulich DB, Fahrenbach MJ, Hultquist ME, Kuh E, Northey EH, Seeger DR, Sickels JP, Smith JM Jr (1946) Synthesis of a compound identical with the L. caseifactor isolated from liver. Science 103: 667–669
Apt W (1970) Tratamiento de la toxoplasmosis (in Spanish). Bol Chil Parasitol 25: 65–68
Archibald HM, Ross CM (1960) Preliminary report on the effect of diaminodiphenylsulphone on malaria in Northern Nigeria. J Trop Med Hyg 63: 25–27
Basu PC, Singh NN, Singh N (1964) Potentiation of activity of diphenylsulfone and pyrimethamine against P. gallinaceumand P. cynomolgi bastianellii. Bull WHO 31: 699–703
Bell PH, Roblin RO Jr (1942) Studies in chemotherapy. VII. A theory of the relation of structure to activity of sulfanilamide type compounds. J Am Chem Soc 64: 2905–2917
Biagi GL, Barbaro AM, Guerra MC, Forti GC, Fracasso ME (1974) Relationship between it and Rm values of sulfonamides. J Med Chem 17: 28–33
Biocca E (1943) Quimioterapia sulfonica da toxoplasmose (in Portuguese). Arq Inst Biol (Sao Paulo) 27: 7–10
Bishop A (1959) Drug resistance in protozoa. Biol Rev 34: 445–500
Bishop A (1963) Some recent developments in the problem of drug resistance in malaria. Parasitology 53: 10 p
Blanchard KC (1941) The isolation of p-aminobenzoic acid from yeast. J Biol Chem 140: 919–926
Bliss EA, Long PH (1941) Observations on the mode of action of sulfanilamide. The antibacteriostatic action of methionine. Bull Johns Hopkins Hosp 69: 14–38
Bock L, Miller GH, Schaper KJ, Seydel JK (1974) Sulfonamide structure activity relationships in a cell-free system 2 Proof for the formation of a sulfonamide-containing folate analog. J Med Chem 17: 23–28
Böhni E, Fust B, Reider J, Schaerer K, Havas L (1969) Comparative toxocological, chemotherapeutic, and pharmacokinetic studies with sulformethoxine and other sulfonamides in animals and man. Chemotherapy 14: 195–226
Boroff DA, Cooper A, Bullowa JGM (1942) Inhibition of sulfapyridine in human serum, exudates, and transudates. J Immunol 43: 341–348
Bratton AC, Marshall EK Jr (1939) A new coupling component for sulphanilamide determination. J Biol Chem 128: 537–550
Bretschneider H, Klotzer W, Spiteller G (1961) Zweitsynthese des 6-sulfanilamido-2,4-dimethoxypyrimidins and Synthese des 6-sulfanilamide-2-methoxy-4,5-dimethylpyrimidins. Monatsh Chemie 92: 128–134
Brown GM (1962) The biosynthesis of folic acid. Inhibition by sulfonamides. J Biol Chem 237: 536–540
Brown GM (1971) The biosynthesis of pteridines. Adv Enzymol 35: 35–77
Brown GM, Weisman RA, Molnar DA (1961) The biosynthesis of folic acid. I. Substrate and cofactor requirements for enzymatic synthesis by cell-free extracts of E. coli. J Biol Chem 236: 2534–2543
Browne SG (1969a) The evaluation of present antileprosy compounds. Adv Pharmacol Chemother 7: 211–246
Browne SG (1969b) Dapsone-resistant M. lepraein a patient receiving dapsone in low doses. Int J Lepr 37: 296–301
Brownlee G, Green AF, Woodbine M (1948) Sulphetrone. A chemotherapeutic agent for tuberculosis. Pharmacology and chemotherapy. Br J Pharmacol 3: 15–28
Brueckner AH (1943) The effect of pH on sulphonamide activity. Yale J Biol Med 15: 813–821
Bushby SRM, Woiwood AJ (1955) Excretion products of 4:4’-diaminodiphenylsulfone. Am Rev Tuberc Pulm Dis 72: 123–125
Bushby SRM, Woiwood AJ (1956) The identification of the major diazotizable metabolite of 4:4’-diaminodiphenylsulphone in rabbit urine. Biochem J 63: 406–408
Buttle GAH, Grey WH, Stephenson D (1936) Protection of mice against streptococcal and other infections byp-aminobenzene sulfonamide and related substances. Lancet I: 1286–1290
Camerino B, Palamidessi G (1960) Derivati della parazina II. Sulfonamdopir (in Italian). Gazz Chim Ital 90: 1802–1815
Coggeshall LT (1938) The cure of P. knowlesimalaria in Rhesus monkeys with sulfanilamide and their susceptibility to reinfection. Am J Trop Med Hyg 18: 715–721
Coggeshall LT, Maier J, Best CA (1941) The effectiveness of two new types of chemotherapeutic agents in malaria: sodium p,p’-diaminodiphenylsulphone-N,N’-di-dextrosesulfonate (Promin) and 2-sulfanilamidopyrimidine (sulfadiazine). JAMA 117: 1077–1081
Colebrook L, Kenny M (1936) Treatment of human peripheral infections and of experimental infections in mice with prontosil. Lancet 1: 1279–1286
Connar RG, Ferguson TB, Sealy WC, Conant NF (1951) Report of a single case with recovery. J Thorac Surg 22: 424–426
Cowdry EV, Ruangsiri C (1941) Influence of promin, starch, and heptaldehyde in experimental leprosy in rats. Arch Pathol 32: 632–640
Cowles PB (1942) Ionization and the bacteriostatic action of sulfonamides. Yale J Biol Med 14: 599–604
Day PL, Langston WC, Darby WJ (1938) Failure of nicotinic acid to prevent nutritional cytopenia in the monkey. Proc Soc Exp Biol Med 38: 860–863
Deininger R, Gutbrod H (1960) Die pharmakodynamische Wirkung des neun Sulfonamido, 2-(p-aminobenzol sulfonamido)-4,5-dimethyloxazole. Arzneim Forsch 10: 612–619
Domagk G (1935) Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch Med Wochenschr 61: 250–253
Domagk G (1957) Twentyfive years of sulfonamide therapy. Ann NY Acad Sci 69: 380–384
Donovick R, Bayan A, Hamre D (1952) The reversal of the activity of antituberculous compounds in vitro. Am Rev Tuberc Pulm Dis 66: 219–227
Ellard GA (1966) Absorption, metabolism and excretion of di-(p-aminophenyl)sulphone (Dapsone) and di(p-aminophenyl)-sulphoxide in man. Br J Pharmacol 26: 212–217
Elslager EF (1974) New perspectives on the chemotherapy of malaria, filariasis and leprosy. Prog Drug Res 18: 99–172
Elslager EF, Worth DF (1965) Repository antimalarial drugs: N,N’-diacetyl-4,4’-diamino-diphenylsulfone and related 4-acylaminodiphenylsulfones. Nature 206: 630–631
Eyles DE (1956) Newer knowledge of the chemotherapy of toxoplasmosis. Ann NY Acad Sci 64: 252–267
Eyles DE, Coleman N (1955) An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot Chemother 5: 529–539
Feldman WH, Hinshaw HC, Moses HE (1942) Promin in experimental tuberculosis. Am Rev Tuberc Pulm Dis 45: 303–308
Ferone R (1973) The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. J Protozool 20: 459–464
Fildes P (1940) A rational approach to research in chemotherapy. Lancet I: 955–957
Findlay GM (1940) The action of sulfanilamide on the virus of Lymphogranuloma venereum. Br J Exp Pathol 21: 356–360
Foernzler EC, Martin AN (1967) Molecular orbital calculations on sulfonamide molecules. J Pharm Sci 56: 608–615
Foerster R (1933) Sepsis im Anschluß an ausgehende Peritoritis. Heilung durch Streptozon. Zentral Haut Geschlechtskr 45: 549–550
Fox CL Jr, Rose MM (1942) Ionisation of sulfonamides. Proc Soc Exp Biol Med 50: 142–145
Friedkin M (1963) Enzymatic aspects of folic acid. Ann Rev Biochem 32: 185–214
Fujita T (1972a) Hydrophobic bonding of sulfonamide drugs with serum albumin. J Med Chem 15: 1049–1056
Fujita T (1972b) Substituent-effect analysis of the rates of metabolism and excretion of sulfonamide drugs. In: Gould RF (ed) Biological correlations — the Hansch approach. American Chemical Society, Washington DC, p 80
Fujita T, Hansch C (1967) Analysis of the structure-activity relationship of the sulfonamide drugs using substituent constants. J Med Chem 10: 991–1000
Fuller AT (1937) Is p-aminobenzenesulfonamide an active agent in prontosil therapy? Lancet II: 194–198
Fust B, Böhni E (1959) Tolerance and antibacterial properties of 2,4-dimethoxy-6-sulfanil-amido-1,3-diazine (Madribon) and some other sulfonamides. Antiobiot Med 6 (I): 3–10
Fust B, Bühni E (1962) Vergleichende experimentelle Untersuchungen mit 5-Methyl-1,3-Sulfanilamido-Isoxazol, anderen Sulfanilamiden and Antibiotica. Schweiz Med Wochenschr 92:1599–1604
Garrett ER, Mielck JB, Seydel JK, Kessler HJ (1969) Kinetics and mechanisms of action of drugs on microorganisms. VIII. Quantification and prediction of the biological activities of m-and p-substituted N’-phenylsulfanilamides by microbial kinetics. J Med Chem 12: 740–745
Garrod LP, James DG, Lewis AAG (1969) The synergy of trimethoprim and sulfonamides. Postgrad Med J [Suppl] 45: 1–84
Geimo P (1908) Liber Sulfamide der p-Amidobenzolsulphonsäure. J Prakt Chem 77: 369–382
Gordon GR, Peters JH, Gelben R, Levy L (1970) Metabolic disposition of dapsone (4,4’-diaminodiphenylsulfone) in animals and man. Proc West Pharmacol Soc 13: 17–24
Gots JS (1953) Occurrence of 4-amino-5-imidazolecarboxamide as a pentose derivative. Nature 172: 256–257
Green HN (1940) The mode of action of sulfanilamide. Br J Exp Pathol 21: 38–64
Greenberg GR (1954) A formylation cofactor. J Am Chem Soc 76: 1458–1459
Greenberg J (1949) The antimalarial activity of 2,4-diamino-6,7-diphenylpterin: its potentiation by sulphadiazine and inhibition by pteroylglutamic acid. J Pharmacol Exp Ther 97: 484–487
Greenberg J, Richeson EM (1950) Potentiation of the antimalarial activity of sulfadiazine by 2,4-diamino-5-aryloxypyrimidines. J Pharmacol Exp Ther 99: 111–119
Greenberg J, Richeson EM (1951) Effect of 2,4-diamino-5-(p-chlorophenoxy)-6-methylpyrimidine and 2,4-diamino-6,7-diphenylpteridine on chlorguanide-resistant strain of Plasmodium gallinaceum. Proc Soc Exp Biol Med 77: 174–176
Griffin MJ, Brown MJ (1964) The biosynthesis of folic acid. III. Enzymatic formation of dihydrofolic acid from dihydropteroic acid and of tetrahydropteroylpolyglutamic acid compound from tetrahydrofolic acid. J Biol Chem 239: 310–316
Heidelberger M, Jacobs WA (1919) Synthesis in the Cinchona series. III. Azodyes derived from hydrocupreine and hydrocupreidine. J Am Chem Soc 41: 2131–2147
Hitchings GH, Burchall JJ (1965) Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol 27: 417–468
Hitzenberger G, Spitzky KH (1962) Experimental studies of a new sulfonamide with depot character: sulfamethoxydiazine. Med Klin 57: 310–313
Ho RI, Corman L, Morse SA, Artenstein MS (1974) Alterations in dihydropteroate synthetase in cell free extracts of sulfanilamide resistant Neisseria meningitidisand Neisseria gonorrhoeae. Antimicrob Agents Chemother 5: 388–392
Horstmann H, Knott T, Scholtan W, Schraufstatter E, Walter A, Worffel U (1961) Beziehungen zwischen Struktur, Wirkung and protein-binding in der 2-Sulfanilamidopyrimidinreihe. Arzneim Forsch 11: 682–684
Hotchkiss RD, Evans AH (1960) Fine structure of a genetically modified enzyme as revealed by relative affinities for modified substrate. Fed Proc 19: 912–925
Hucker HB (1970) Species difference in drug metabolism. Am Rev Pharmacol 10: 99–118
Irmscher K, Gabe D, Jahnke K, Scholtan W (1966) Untersuchungen zur SerumeiweiBbil- dung and zur renalen Elimination von isomeren Sulfonamiden (5-Sulfanilamido-3-at-hy1–1,2,4-thiodiazol and 5-Sulfanilamido-2-athyl-1,3,4-thiodiazol. Arzneim Forsch 16: 1019–1025
Iwai K, Okinaka O (1968) The biosynthesis of folic acid compounds in plants. I. Enzymatic formation of dihydropteroic acid, dihydrofolic acid from 2-amino-4-hydroxy-6-substituted pteridine by cell free extracts of pea seedlings. J Vitaminol (Kyoto) 14: 160–169
Jaenicke L, Chan PC (1960) Die Biosynthese der Folsäure. Angew Chem [Engl] 72: 752–753
Jardetzky O, Wade-Jardetzky NG (1965) The mechanism of the binding on sulfonamides to bovine serum albumin. Mol Pharmacol 1: 214–230
Joyner LP, Davies SFM, Kendall SB (1963) Chemotherapy of coccidiosis. In: Schnitzer RJ, Hawking F (eds) Experimental chemotherapy. Academic Press, New York, p445
Kakemi K, Arita T, Koizumi T (1965) Absorption and excretion of drugs. XXIII. Some pharmacokinetic aspects of absorption and excretion of sulfonamides 5. Acetylation of sulfonamides. Yakuzaigaku 25: 22–2
Kendall SB (1950) A comparison of the efficacy of sulphamethazine and sulphaquinazoline in the control of experimentally induced caecal coccidiosis in chicks. Vet Record 62: 381–382
Kendall SB, Joyner LP (1958) Potentiation of the coccidiostatic effects of sulphadimidine by five different folic acid antagonists. Vet Record 70: 632–634
Koizumi T, Arita T, Kakemi K (1964) Absorption and excretion of drugs. XXI. Some pharmacokinetic aspects of absorption and excretion of sulfonamides. 3. Excretion from the kidney. Chem Pharm Bull (Tokyo) 12: 428–432
Krüger-Thiemer E (1966) Die Lösung pharmakologischer Probleme durch Rechenautomaten. Arzneim Forsch 16: 1431–1442
Krüger-Thiemer E, Wempe E, Töpfor M (1965) Die antibakterielle Wirkung des nicht eiweißgebundenen Anteils der Sulfanilamide im menschlichen Plasmawasser. Arzneim Forsch 15: 1309–1317
Kuhn R, Schwartz K (1941) Isolation of the growth-promoting substance H from yeast. Chem Ber 74 B: 1617–1624
Kurnosova LM, Lenkevich MM (1964) Mode of action of sulfonamides on trachoma virus. Acta Virol (Praha) 8: 350–358
Lampen JO, Jones MJ (1946) The antagonism of sulfonamide inhibition of certain lactobacilliand enterococciby pteroylglutamic acid and related compounds. J Biol Chem 166: 435–448
Lampen JO, Jones MJ (1947) The growth-promoting and antisulfonamide activity of paminobenzoicacid, pteroylglutamic acid, and related compounds for L. arabinosusand Strept. plantarum. J Biol Chem 170: 133–146
Landy M, Larkum NW, Oswald EJ, Streightoff F (1943) Increased synthesis ofp-aminobenzoic acid associated with the development of resistance in Staph. aureus. Science 97: 265–267
Lascelles J, Woods DD (1952) The synthesis of folic acid by Bacterium coliand Staphylococcus aureusand its inhibition by sulphonamides. Br J Exp Pathol 33: 288–303
Lehr D (1957) Clinical toxicity of sulfonamides. Ann NY Acad Sci 9: 417–447
Levaditi C (1941) Woods phenomenon and N-containing sulfonamides, sulfoxides, and sulfones. C R Soc Biol 135: 1109–1111
Levine PP (1939) The effect of sulfanilamide on the course of experimental avian coccidiosis. Cornell Vet 29: 309–320
Levine PP (1941) The coccidiostatic effect of sulfaguanidine. Cornell Vet 31: 107–112
Lockwood JS, Coburn AF, Stokinger HE (1938) Studies on the mechanism of the action of sulfanilamide. JAMA 111: 2259–2264
Macleod CM (1940) The inhibition of the bacteriostatic action of sulfonamide drugs by substances of animal and bacterial origin. J Exp Med 72: 217–232
Maier J, Riley E (1942) Inhibition of antimalarial action of sulfonamides by p-aminobenzoic acid. Proc Soc Exp Biol Med 50: 152–154
Marshall EK Jr (1937) Determination of sulfanilamide in blood and urine. J Biol Chem 122: 263–273
Martin BK (1965) Potential effects of the plasma proteins on drug distribution. Nature 207: 274–276
McCallum FO, Findlay GM (1938) Chemotherapeutic experiments on the virus of Lymphogranuloma inguinale in the mouse. Lancet II: 136–138
McCullough JL, Maren TH (1974) Dihydropteroate synthetase from Plasmodium berghei. Isolation, properties, and inhibition by dapsone and sulfadiazine. Mol Pharmacol 10: 140–145
Mcllwain H (1942) Correlation of drug action in vitro and in vivo through specific antagonists: Sulfanilamide and p-aminobenzoate. Br J Exp Pathol 23: 265–271
Mietzsch F (1938) The chemotherapy of bacterial infections. Chem Ber 71 A: 15–28
Mietzsch F, Klarer J (1935) Verfahren zur Herstellung von Azoverbindungen. Deutsches Reichspatent 607: 537
Miller AK (1944) Folic acid and biotin synthesis by sulphonamide-sensitive and sulphonamide-resistant strains of E. coli. Proc Soc Exp Biol Med 57: 151–153
Miller AK, Bruno P, Berglund RM (1947) The effect of sulfathiazole on the in vitro synthesis of certain vitamins by E. coli. J Bacteriol 54: 9
Miller GH, Doukas PH, Seydel JK (1972) Sulfonamide structure-activity relationship in a cell-free system. Correlation of inhibition of folate synthesis with antibacterial activity and physicochemical parameters. J Med Chem 15: 700–706
Mitchell HK, Snell EE, Williams RJ (1941) The concentration of folic acid. J Am Chem Soc 63: 22–84
Mitsuda H, Suzuki Y (1968) Pteridines in plants. III. Biogenesis of folic acid in green leaves; inhibitors acting on the biosynthetic pathway for the formation of dihydropteroic acid from guanylic acid. J Vitaminol (Kyoto) 14: 106–120
Mitsuhashi S, Inoue K, Inoue M (1977) Nonconjugative plasmids encoding sulfanilamide resistance. Antimicrob Agents Chemother 12: 418–422
Morgan HR (1948) Studies on the relationship of pteroylglutamic acid to the growth of Psittacosisvirus (strain 6 BC). J Exp Med 88: 285–294
Moriguchi I, Wada S (1968) Protein bindings. IV. Relations of an index for electronic structure to binding constant with serum albumin and bacteriostatic activities of sulfonamides. Chem Pharm Bull (Tokyo) 16: 734–738
Moriguchi I, Wada S, Nishizawa T (1968) Protein bindings. III. Binding of sulfonamides to bovine serum albumin. Chem Pharm Bull (Tokyo) 16: 601–605
Morrison NE (1968) Sulfone resistant states (Abstr 199). Int J Lepr 36: 652
Moulder JW (1962) The biochemistry of intracellular parasitism. University of Chicago Press, Chicago, p 105
Nagate N, Matsuhisa I, Inoue K, Mitsuhashi S (1978) Plasmid-mediated sulfanilamide resistance. Microbiol Immunol 22: 367–375
Nichol CA, Anton AH, Zakrzewski SF (1955) A labile precursor of citrovorum factor. Science 121: 275–279
Nichols RL, Jones WF Jr, Finland M (1956) Sulfamethoxypyridazine: preliminary observations on absorption and excretion of a new long-acting antibacterial sulfonamide. Proc Soc Exp Biol Med 92: 637–640
Nimmo-Smith RH, Lascelles J, Woods DD (1948) Synthesis of folic acid by Streptobac- terium plantarumand its inhibition by sulfonamides. Br J Exp Pathol 29: 264–281
Nogami H, Hasegawa A, Hanano M, Imaoka K (1968) Absorption and excretion of drugs. XII. Pharmacokinetic studies on urinary excretion of sulfonamides. Yakugaku Zashi 88: 893–899
Okinaka O, Iwai K (1969) Radioassay for dihydropteroate synthesizing enzyme activity. Anal Biochem 31: 174–182
Ortiz PJ (1970) Dihydrofolate and dihydropteroate synthesis by partially purified enzymes from wild-type and sulfonamide-resistant pneumococci. Biochemistry 9:355–361
Osborn MJ, Huennekens FM (1958) Enzymatic reduction of dihydrofolic acid. J Biol Chem 233: 969–974
Pato ML, Brown GM (1963) Mechanisms of resistance of E. colito sulfonamides. Arch Biochem Biophys 103: 443–448
Pearson JMH, Petit JMS, Rees RJW (1968) Studies on sulfone resistance in leprosy. 3. A case of partial resistance. Int J Lepr 36: 171–178
Peters W (1974) Recent advances in antimalarial chemotherapy and drug resistance. Adv Parasitol 12: 69–114
Pfiffner JJ, Binkley SB, Bloom ES, Brown RA, Bird OD, Emmett AD, Hogan AG, O’Dell BL (1943) Isolation of the antianemia factor (vit Bc) in crystalline form from liver. Science 97: 404–405
Pfiffner JJ, Binkley SB, Bloom ES, O’Dell BL (1947) Isolation and characterisation of vit Bc from liver and yeast. Occurrence of an acid-labile chick antianaemia factor in liver. J Am Chem Soc 69: 1476–1487
Ramakrishnan SP, Basu PC, Singh H, Singh N (1962) Studies on the toxicity and action of diaminodiphenylsulfone (DDS) in avian and simian malaria. Bull WHO 27: 213–221
Ramakrishnan SP, Basu PC, Singh N, Wattal BL (1963) A study on the joint action of diaminodiphenylsulfone (DDS) and pyrimethamine in the sporogony cycle of plasmodium gallinaceum. Potentiation of the sporontocidal activity of pyrimethamine by DDS. Indian J Malariol 17: 141–148
Rastelli A, De Beneditti PG, Battistuzzi GA, Albasini A (1975) The role of anionic, imidic and amidic forms in structure-activity relationships. Correlation of electronic indices and bacteriostatic activity in sulfonamides. J Med Chem 18: 963–967
Ratner S, Blanchard M, Coburn AF, Green DE (1944) Isolation of a peptide of p-aminobenzoic acid from yeast. J Biol Chem 155: 689–690
Reber H, Rutishauser G, Tholen H (1964) Untersuchungen am Menschen mit Sulfamethoxazol und Sulforthodimothoxin. In: Kuemmerle HP, Preziosi (eds) Third Int Congr Chemother Stuttgart 1963, vol 1. Thieme, Stuttgart, p 648
Reynolds JJ, Brown GM (1964) The biosynthesis of folic acid. IV. Enzymatic synthesis of dihydrofolic acid from guanine and ribose compounds. J Biol Chem 239: 317–325
Richey DP, Brown GM (1969) The biosynthesis of folic acid IX Purification and properties of the enzymes required for the formation of dihydropteroic acid. J Biol Chem 244: 1582–1592
Rieder J (1963) Physikalisch-chemische und biologische Untersuchungen an Sulfonamiden. Arzneim Forsch 13:81–88,89–95, 95–103
Rist N, Bloch F, Hamon V (1940) Inhibiting action of sulfonamide and of a sulfone on the multiplication in vitro and in vivo of tubercle bacillus. Ann Inst Pasteur 64: 203–237
Robinowitz JC, Himes RH (1960) Folic acid coenzymes. Fed Proc 19: 963–970
Roland S, Ferone R, Harvey RJ, Styles YL, Morrison RW (1979) The characteristics and significance of sulfonamides as substrates for E. colidihydropteroate synthase. J Biol Chem 254: 10337–10345
Rubbo SD, Gillepsie JM (1940) p-Aminobenzoic acid as a bacterial growth factor. Nature 146:838–839
Rubbo SD, Maxwell M, Fairbridge RA, Gillespie JM (1941) The bacteriology, growth factor requirements and fermentation reactions of Clostridium acctobutylicumWeizman. Aust J Exp Biol Med Sci 19: 185–198
Sabin AB, Warren J (1941) Therapeutic effect of the sulfonamides on infection by an intracellular protozoan (Toxoplasma). J Bacteriol 41: 80
Sauberlich HE, Baumann CA (1948) A factor required for the growth of Leuconostoc citrovorum. J Biol Chem 176: 165–173
Schmelkes FC, Wyss O, Marks HC, Ludwig BJ, Stranskov FB (1942) Mechanism of sulfonamide action. I. Acidic dissociation and antibacterial effect. Proc Soc Ex Biol Med 50: 145–148
Schnaare RS, Martin AN (1965) Quantum chemistry in drug design. J Pharm Sci 54: 1707–1713
Scholtan W (1963) The protein binding of long acting sulfonamides. Chemotherapia 6: 180–189
Scholtan W (1968) Die hydrophobe Bindung der Pharmaka an Human-Albumin und Ribonucleinsäure. Arzneim Forsch 18: 505–517
Schwenker G (1962) Infrared and nuclear magnetic resonance spectrophotometric study of the structure of sulfanil-guanidine. Arch Pharm (Weinheim) 295: 753–758
Seeler AO, Graessle O, Dusenbery ED (1943) The effect of pAB on the chemotherapeutic activity of sulfonamides in Lymphogranuloma venereumand in duck malaria. J Bacteriol 45: 205–209
Selbie FR (1940) The inhibition of the action of sulfanilamide in mice by p-aminobenzoic acid. Br J Exp Pathol 21: 90–93
Seydel JK (1966) Prediction of in vitro activity of sulfonamides, using Hammett constants or spectrophotometric data of the basic amines for calculation. Mol Pharmacol 2: 259–265
Seydel JK (1968) Molecular basis for the action of chemotherapeutic drugs: structure-activity studies on sulfonamides. In: Ariens EJ (ed) Physico-chemical aspects of drug action. Pergamon, New York, p 169
Seydel JK (1971a) Prediction of the in vitro activity of sulfonamides synthesised from simple amines by use of electronic data obtained from simple amines. J Med Chem 14: 724–729
Seydel JK (1971b) Physicochemical approaches to the rational development of new drugs. In: Ariens EJ (ed) Drug design. Academic Press, New York, p 343
Seydel JK, Wempe E (1964) Physikalisch-chemische und bakteriologische Untersuchungen an N’-acylierten Sulfamiden. Arzneim Forsch 14: 705–708
Seydel JK, Krüger-Thiemer E, Wempe E (1960) Relation between antibacterial activity and IR of sulfanilamide. Z Naturforsch [C] 15 B: 628–641
Shepard CC, Tolentino JG, McRae DN (1968) The therapeutic effect of 4,4’-diacetyldi-aminodiphenylsulfone (DADDS) in leprosy. Am J Trop Med Hyg 17: 192–201
Shiota T (1959) Enzymic synthesis of folic acid-like compounds by cell-free extracts of Lactobacillus arabinosus. Arch Biochem Biophys 80: 155–161
Shiota T, Disraely MN (1961) The enzymic synthesis of dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine and p-aminobenzoylglutamate by extracts of Lactobacillus plantarum. Biochim Biophys Acta 52: 467–473
Shiota T, Disraely MN, McCann MP (1964) The enzymatic synthesis of folate-like compounds from hydroxymethyldihydropteridine pyrophosphate. J Biol Chem 239: 2259–2266
Shiota T, Baugh CM, Jackson R, Dillard R (1969) The enzymatic synthesis of hydroxymethyl-dihydrofolate. Biochemistry 8: 5022–5028
Shive W, Ackerman WC, Gordon M, Getzendaner ME, Eakin RE (1947) 5(4)-Amino-4(5)-imidazolecarboxamide, a precursor of purines. J Am Chem Soc 69:725–726
Sköld O (1976) R-Factor-mediated resistance to sulfonamides by a plasmid-borne drug resistance dihydropteroate synthase. Antimicrob Agents Chemother 9: 49–54
Snell EE, Mitchell HK (1943) Some sulfonamide antagonists as growth factors for lactic acid bacteria. Arch Biochem 1: 93–101
Snell EE, Peterson WH (1940) Growth factors for bacteria. X. Additional factors required by certain lactic acid bacteria. J Bact 39: 273–284
Stamp TC (1939) Bacteriostatic action of sulphanilamide in vitro. Lancet II: 10–17
Stetten MR, Fox CL (1945) An amine formed by bacteria during sulphonamide bacteriostasis. J Biol Chem 161: 333–349
Strauss AM, Kliggman AM, Pillsbury DM (1951) The chemotherapy of actinomycosis and nocardiosis. Am Rev Tuberc Pulm Dis 63: 441–448
Struller T (1968) Progress in sulfonamide research. Prog Drug Res 12: 389–457
Tabor H, Wyngaarden L (1954) The enzymatic formation of formimino-tetrahydrofolic acid, 5,10-methylenetetrahydrofolic acid and 10-formyltetrahydrofolic acid in the metabolism of formimino-glutamic acid. J Biol Chem 234: 1830–1846
Tarizzo ML (1972) Chemotherapy of trachoma. WHO Chronicle 26: 99–101
Thompson PE (1967) Antimalarial studies on 4,4’-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals. Int J Lepr 35: 605–615
Thompson PE, Olszewski B, Waitz JA (1965) Laboratory studies on the repository antimalarial activity of 4,4’-diacetyl-aminodiphenylsulfone, alone and mixed with cycloguanil pamoate (CI-501). Am J Trop Med Hyg 14: 343–353
Toth-Martinez RJ, Papp S, Dinya Z, Hernadi FJ (1975) New vistas for p-aminobenzoate participation in the biosynthesis of dihydrofolate: a tentative model of the tetrahydrofolate multienzyme complex. Biosystems 7: 172–182
Trefouël J, Trefouël MMe J, Nitti F, Bovet D (1935) Activite du p-aminophenylsulfamide sur les infections streptococciques experimentales de la souris et du lapin. C R Soc Biol 120: 756–758
Tripod J, Neipp L, Padowtz W, Sackmann W (1960) Relations experimentales entre l’action curative et les taux sanguins de sulfamides, en particulier du sulfaphenazol. Antibiot Chemotherapia 8: 17–31
Tschesche R (1947) A new explanation of the mode of action of the sulfonamides. Z Naturforsch [C] 2b: 10–11
Vieira E, Shaw E (1961) The utilisation of purines in the biosynthesis of folic acid. J Biol Chem 236: 2507–2510
Walter RD, Königk E (1974) Biosynthesis of folic acid compounds in plasmodia; purification and properties of 7,8-dihydropteroate synthesising enzyme from Plasmodium chabaudi. Hoppe Seylers Z Physiol Chem 355: 431–437
Watanabe T (1963) Infective heredity of multiple drug resistance in bacteria. Bacteriol Rev 27: 87–115
Weinstein L, Madoff MA, Samet CM (1960) The sulfonamides. Engl J Med 263:793–800, 842–849, 900–907
Weisman RA, Brown GM (1964) The biosynthesis of folic acid. V. Characteristics of the enzyme system that catalyses the synthesis of dihydropteroic acid. J Biol Chem 239: 326–331
White PJ, Woods DD (1965) The synthesis ofp-aminobenzoic acid and folic acid by staphylococci sensitive and resistant to sulphonamides. J Gen Microbiol 40: 243–253
Williams RT, Parke DV (1964) Metabolic fate of drugs. Ann Rev Pharmacol 4: 85–114
Wise EM Jr, Abou-Donia MM (1975) Sulfonamide resistance mechanism in E. coli: R plasmids can determine sulfonamide-resistant dihydropteroate syntheses. Proc Natl Acad Sci USA 72: 2621–2625
Wolf B, Hotchkiss RD (1963) Genetically modified folic acid synthesising enzymes of pneumococcus. Biochemistry 2: 145–150
Woods DD (1940) Relation of p-aminobenzoic acid to mechanism of action of sulphanilamide. Br J Exp Pathol 21: 74–90
Woods DD (1954) Metabolic relations between p-aminobenzoic and folic acids in microorganisms. In: Chemistry and biology of pteridines, CIBA Foundation Symposium. Little Brown, Boston, Mass, p 220
Yamazaki M, Aoki M, Kamada A (1968) Biological activities of drugs. III. Physicochemical factors affecting the excretion of sulfonamides in rabbits. Chem Pharm Bull (Tokyo) 16: 707–714
Yamazaki M, Kakeya N, Morishita T, Kamada A, Aoki A (1970) Biological activity of drugs. X. Relation of structure to the bacteriostatic activity of sulfonamides (1). Chem Pharm Bull (Tokyo) 18: 702–707
Ziegler-Gunder I, Simon H, Wacker A (1956) Metabolism of guanine-2–14C and hypoxanthine-8–14C in amphibians. Zentral Naturforsch IIb: 82–85
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Anand, N. (1983). Sulfonamides: Structure-Activity Relationships and Mechanism of Action. In: Hitchings, G.H. (eds) Inhibition of Folate Metabolism in Chemotherapy. Handbook of Experimental Pharmacology, vol 64. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81890-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-81890-5_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81892-9
Online ISBN: 978-3-642-81890-5
eBook Packages: Springer Book Archive